Nachrichten zur H. Lundbeck A/S Aktie

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 16 February 2024 - H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons…

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 20 December 2023 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons…

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 4 December 2023 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons…

Lundbeck raises financial guidance range for the full year 2022

Valby, Denmark, November 8, 2022 - H. Lundbeck A/S (Lundbeck) announced that the financial guidance range for the full-year 2022…

New study presented at ECPN 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

VALBY, Denmark, Oct. 18, 2022 /PRNewswire/ -- H. Lundbeck A/S (Lundbeck) announced positive data showing Trintellix/Brintellix® (vortioxetine) significantly reduced depressive…

New study presented at ECNP 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

H. Lundbeck A/S (Lundbeck) announced positive data showing Trintellix/Brintellix[®] (vortioxetine) significantly reduced depressive symptoms and improved cognitive performance in people…

New study presented at ECPN 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

H. Lundbeck A/S (Lundbeck) announced positive data showing Trintellix/Brintellix[®] (vortioxetine) significantly reduced depressive symptoms and improved cognitive performance in people…

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Lundbeck raises financial guidance range for the full year 2022

New study presented at ECPN 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

New study presented at ECNP 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

New study presented at ECPN 2022 finds that vortioxetine improves depressive symptoms and cognitive function in patients with Major Depressive Disorder and co-morbid dementia

dpa-AFX ProFeed